Recruiting
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
NCT06418477
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China